Literature DB >> 12950523

Use of the implantable loop recorder in evaluation of patients with unexplained syncope.

Andrew D Krahn1, George J Klein, Allan C Skanes, Raymond Yee.   

Abstract

Syncope is a complex symptom with multiple potential etiologies that can be difficult to establish. The major obstacles to diagnosis are the periodic and unpredictable nature of events and the high spontaneous remission rate. Short-term ECG monitoring often is unproductive when initial noninvasive testing is negative due to the low probability of recurrence during the brief monitoring period. Implantable loop recorders extend the ability to monitor cardiac patients, enhancing the diagnostic yield to as high as 85% in difficult to diagnose syncope. Several recent studies suggest that prolonged monitoring with an implantable loop recorder has a role in patients with syncope and conduction disturbances, negative tilt testing, and unexplained seizures, and may be superior to conventional testing with tilt and electrophysiologic studies.

Entities:  

Mesh:

Year:  2003        PMID: 12950523     DOI: 10.1046/j.1540-8167.14.s9.19.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

1.  Idiopathic ventricular arrhythmias detected by an implantable loop recorder in a child with exercise-induced syncope.

Authors:  Celal Akdeniz; Isa Ozyilmaz; Murat Saygi; Yakup Ergul; Volkan Tuzcu
Journal:  Tex Heart Inst J       Date:  2013

2.  P- and R-wave Amplitude Sensed by Reveal LINQ™ Loop Recorder in Pediatric Patients.

Authors:  Roshan D'Souza; Elizabeth Thomas; Scott Macicek; Peter Aziz; Jill K Shivapour; Christopher Snyder
Journal:  J Innov Card Rhythm Manag       Date:  2017-01-15

3.  R-wave sensing in an implantable cardiac monitor without ECG-based preimplant mapping: results from a multicenter clinical trial.

Authors:  Andrew D Krahn; Robert A Pickett; Scott Sakaguchi; Naushad Shaik; Jian Cao; Holly S Norman; Patricia Guerrero
Journal:  Pacing Clin Electrophysiol       Date:  2013-12-02       Impact factor: 1.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.